Catherine Paul

Professor

France

Research Interests

Explore related searches

Professors in France Professors in Immunology Immunology professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Catherine Paul is a faculty member at EPHE PSL in France. Her research focuses on the development of innovative imaging technologies and therapeutic strategies, particularly in the context of cancer treatment. Recent articles highlight her work on NIR-II Aza-BODIPY dyes for targeted imaging and antibody-drug conjugates, as well as the design of heterometallic complexes for anti-proliferative applications. She is committed to advancing the understanding of tumor biology and improving therapeutic outcomes in oncology.

Articles (14)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Université de Franche-Comté

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Catherine Paul

Research Interests

Explore related searches

Contact this professor

About

Articles (14)

NIR-II aza-BODIPY Platform for the Development of a Fluorescent Antibody Drug Conjugate

Comparison of the In Vitro and In Vivo Behavior of a Series of NIR-II-Emitting Aza-BODIPYs Containing Different Water-Solubilizing Groups and Their Trastuzumab Antibody Conjugates

From the design of innovative Ti‐Pt heterometallic complexes to the development of highly anti‐proliferative water‐soluble cationic titanocenes

Development of an Immuno-SPECT/Fluorescent Bimodal Tracer Targeting Human or Murine PD-L1 on Preclinical Models

GTN Enhances Antitumor Effects of Doxorubicin in TNBC by Targeting the Immunosuppressive Activity of PMN-MDSC

NIR-II Aza-BODIPY Dyes Bioconjugated to Monoclonal Antibody Trastuzumab for Selective Imaging of HER2-Positive Ovarian Cancer

NIR-II Aza-BODIPY Dyes Bioconjugated to Monoclonal Antibody Trastuzumab for Selective Imaging of HER2-Positive Ovarian Cancer

First Comparison Study of the In Vitro and In Vivo Properties of a Randomly and Site-Specifically Conjugated SPECT/NIRF Monomolecular Multimodal Imaging Probe (MOMIP) Based on an aza-BODIPY Fluorophore

First Comparison Study of the In Vitro and In Vivo Properties of a Randomly and Site-Specifically Conjugated SPECT/NIRF Monomolecular Multimodal Imaging Probe (MOMIP) Based on an aza-BODIPY Fluorophore

cIAP1/TRAF2 interplay promotes tumor growth through the activation of STAT3

cIAP1/TRAF2 interplay promotes tumor growth through the activation of STAT3

Development of Anti-LRRC15 Small Fragments for Imaging Purposes Using a Phage-Display ScFv Approach

Development of Anti-LRRC15 Small Fragments for Imaging Purposes Using a Phage-Display ScFv Approach

Protein Kinase Inhibitor-Mediated Immunoprophylactic and Immunotherapeutic Control of Colon Cancer

Collaborators (7)

francois ghiringhelli

Christine Goze

Lucie Sancey

Xavier Le Guével

Jean-luc Coll

Benoit Busser

Frédérique Végran

Make your next move.